Literature DB >> 24709425

Lung-derived factors mediate breast cancer cell migration through CD44 receptor-ligand interactions in a novel ex vivo system for analysis of organ-specific soluble proteins.

Jenny E Chu1, Ying Xia2, Benjamin Chin-Yee2, David Goodale2, Alysha K Croker1, Alison L Allan3.   

Abstract

Breast cancer preferentially metastasizes to lung, lymph node, liver, bone, and brain. However, it is unclear whether properties of cancer cells, properties of organ microenvironments, or a combination of both is responsible for this observed organ tropism. We hypothesized that breast cancer cells exhibit distinctive migration/growth patterns in organ microenvironments that mirror common clinical sites of breast cancer metastasis and that receptor-ligand interactions between breast cancer cells and soluble organ-derived factors mediate this behavior. Using an ex vivo model system composed of organ-conditioned media (CM), human breast cancer cells (MDA-MB-231,MDA-MB-468, SUM149, and SUM159) displayed cell line-specific and organ-specific patterns of migration/proliferation that corresponded to their in vivo metastatic behavior. Notably, exposure to lung-CM increased migration of all cell lines and increased proliferation in two of four lines (P < .05). Several cluster of differentiation (CD) 44 ligands including osteopontin (OPN) and L-selectin (SELL) were identified in lung-CM by protein arrays. Immunodepletion of SELL decreased migration of MDA-MB-231 cells, whereas depletion of OPN decreased both migration and proliferation. Pretreatment of cells with a CD44-blocking antibody abrogated migration effects (P < .05). "Stemlike" breast cancer cells with high aldehyde dehydrogenase and CD44 (ALDH(hi)CD44(+)) responded in a distinct chemotactic manner toward organ-CM, preferentially migrating toward lung-CM through CD44 receptor-ligand interactions (P < .05). In contrast, organ-specific changes in migration were not observed for ALDH(low)CD44(-) cells. Our data suggest that interactions between CD44(+) breast cancer cells and soluble factors present in the lung microenvironment may play an important role in determining organotropic metastatic behavior.
Copyright © 2014 Neoplasia Press, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24709425      PMCID: PMC3978398          DOI: 10.1593/neo.132076

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  52 in total

1.  Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization.

Authors:  R Cailleau; M Olivé; Q V Cruciger
Journal:  In Vitro       Date:  1978-11

Review 2.  Chemotaxis in cancer.

Authors:  Evanthia T Roussos; John S Condeelis; Antonia Patsialou
Journal:  Nat Rev Cancer       Date:  2011-07-22       Impact factor: 60.716

3.  Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice.

Authors:  J E Price; A Polyzos; R D Zhang; L M Daniels
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

Review 4.  CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.

Authors:  Karin Williams; Karan Motiani; Premkumar Vummidi Giridhar; Susan Kasper
Journal:  Exp Biol Med (Maywood)       Date:  2013-03

5.  Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice.

Authors:  JangBo Lee; Satoshi Kuroda; Hideo Shichinohe; Jun Ikeda; Toshitaka Seki; Kazutoshi Hida; Mitsuhiro Tada; Ken-ichi Sawada; Yoshinobu Iwasaki
Journal:  Neuropathology       Date:  2003-09       Impact factor: 1.906

6.  Murine lymph node-derived stromal cells effectively support survival but induce no activation/proliferation of peripheral resting T cells in vitro.

Authors:  Yan-Wen Zhou; Sayoko Aritake; Agustina Tri Endharti; Jianghong Wu; Akemi Hayakawa; Izumi Nakashima; Haruhiko Suzuki
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

7.  Genes that mediate breast cancer metastasis to the brain.

Authors:  Paula D Bos; Xiang H-F Zhang; Cristina Nadal; Weiping Shu; Roger R Gomis; Don X Nguyen; Andy J Minn; Marc J van de Vijver; William L Gerald; John A Foekens; Joan Massagué
Journal:  Nature       Date:  2009-05-06       Impact factor: 49.962

Review 8.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

9.  The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the "Seed" and the "Soil"?

Authors:  Jenny E Chu; Alison L Allan
Journal:  Int J Breast Cancer       Date:  2011-11-03

10.  Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo.

Authors:  Swantje I Hammerschmidt; Manuela Ahrendt; Ulrike Bode; Benjamin Wahl; Elisabeth Kremmer; Reinhold Förster; Oliver Pabst
Journal:  J Exp Med       Date:  2008-10-13       Impact factor: 14.307

View more
  20 in total

1.  The transcriptional repressor BCL11A promotes breast cancer metastasis.

Authors:  Darcie D Seachrist; Molly M Hannigan; Natasha N Ingles; Bryan M Webb; Kristen L Weber-Bonk; Peng Yu; Gurkan Bebek; Salendra Singh; Steven T Sizemore; Vinay Varadan; Donny D Licatalosi; Ruth A Keri
Journal:  J Biol Chem       Date:  2020-06-23       Impact factor: 5.157

2.  Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior.

Authors:  Matthew M Piaseczny; Graciella M Pio; Jenny E Chu; Ying Xia; Kim Nguyen; David Goodale; Alison Allan
Journal:  J Vis Exp       Date:  2016-06-13       Impact factor: 1.355

3.  Transforming Growth Factor-induced Protein Promotes NF-κB-mediated Angiogenesis during Postnatal Lung Development.

Authors:  Min Liu; Cristiana Iosef; Shailaja Rao; Racquel Domingo-Gonzalez; Sha Fu; Paige Snider; Simon J Conway; Gray S Umbach; Sarah C Heilshorn; Ruby E Dewi; Mar J Dahl; Donald M Null; Kurt H Albertine; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

4.  Effect of dacarbazine on CD44 in live melanoma cells as measured by atomic force microscopy-based nanoscopy.

Authors:  Xun Huang; Jiexiang He; Huan-Tian Zhang; Kai Sun; Jie Yang; Huajun Wang; Hongxin Zhang; Zhenzhao Guo; Zhen-Gang Zha; Changren Zhou
Journal:  Int J Nanomedicine       Date:  2017-12-18

5.  Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells.

Authors:  Graciella M Pio; Ying Xia; Matthew M Piaseczny; Jenny E Chu; Alison L Allan
Journal:  PLoS One       Date:  2017-05-12       Impact factor: 3.240

6.  A CD44v+ subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity.

Authors:  Jing Hu; Gang Li; Peiyuan Zhang; Xueqian Zhuang; Guohong Hu
Journal:  Cell Death Dis       Date:  2017-03-16       Impact factor: 8.469

7.  The molecular underpinning of geminin-overexpressing triple-negative breast cancer cells homing specifically to lungs.

Authors:  Eman Sami; Danielle Bogan; Alfredo Molinolo; Jim Koziol; Wael M ElShamy
Journal:  Cancer Gene Ther       Date:  2021-03-15       Impact factor: 5.987

8.  L-Selectin expression is associated with inflammatory microenvironment and favourable prognosis in breast cancer.

Authors:  Sarita Kumari; Mohit Arora; Jay Singh; Shyam S Chauhan; Sachin Kumar; Anita Chopra
Journal:  3 Biotech       Date:  2021-01-08       Impact factor: 2.893

9.  Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells.

Authors:  S Saleh; D E Thompson; J McConkey; P Murray; R A Moorehead
Journal:  BMC Cancer       Date:  2016-06-10       Impact factor: 4.430

10.  3D printed intelligent scaffold prevents recurrence and distal metastasis of breast cancer.

Authors:  Xuelei Shi; Yanxiang Cheng; Jian Wang; Haoxiang Chen; Xiaocheng Wang; Xinghuan Li; Weihong Tan; Zhikai Tan
Journal:  Theranostics       Date:  2020-08-29       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.